Wednesday, July 29, 2015

Pricey Drugs Largely To Blame For Uptick In National Health Expenditures

New CMS projections of national health expenditures show a rise in spending growth over the next decade. Pricey new drugs for diseases like hepatitis C and cancer are largely responsible for the trend.

No comments:

Post a Comment